In a NASH mouse model, TLR9 signaling induces production of IL-1β by Kupffer cells, leading to steatohepatitis, inflammation, and fibrosis via induction of IL-1β [25]. Here, IL1B is linked to metabolic dysfunction-associated steatohepatitis.